|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA01100015
|
2-amino-heptanoic acid
|
2-amino-heptanoic acid
|
|
C7H15NO2
|
145.110279
|
|
LMFA01090084
|
9,10-dibromo-stearic acid
|
9,10-dibromo-octadecanoic acid
|
|
C18H34Br2O2
|
440.092551
|
|
LMFA01050212
|
2-hydroxy-tricosanoic acid
|
2-hydroxy-tricosanoic acid
|
FA 23:0;O
|
C23H46O3
|
370.344696
|
|
LMFA01090101
|
6-bromo-tricosa-5E,9Z-dienoic acid
|
6-bromo-tricosa-5E,9Z-dienoic acid
|
|
C23H41BrO2
|
428.228991
|
|
LMFA01090101
|
6-bromo-tricosa-5E,9Z-dienoic acid
|
6-bromo-tricosa-5E,9Z-dienoic acid
|
|
C23H41BrO2
|
428.228991
|
|
LMFA07070017
|
(4Z)-decenoylcarnitine
|
3-[(4Z)-dec-4-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1
|
C17H31NO4
|
313.225309
|
|
LMFA07010566
|
SFE 3:0(2Me)/3:0(2Me)
|
2-Methylpropyl 2-methylpropionate
|
WE 8:0
|
C8H16O2
|
144.115030
|
|
LMFA08010023
|
S-Acetyldihydrolipoamide
|
6-(acetylsulfanyl)-8-sulfanyloctanamide
|
|
C10H19NO2S2
|
249.085720
|
|
LMFA01090048
|
14-fluoro-myristic acid
|
14-fluoro-tetradecanoic acid
|
|
C14H27FO2
|
246.199509
|
|
LMFA00000018
|
11,15-dichloro-docosane-1,14-disulfate
|
11,15-dichloro-docosane-1,14-disulfate
|
|
C22H44Cl2O8S2
|
570.185468
|
|
LMFA07010905
|
Hexyl 2-methyl-4-pentenoate
|
hexyl 2-methylpent-4-enoate
|
WE 12:1
|
C12H22O2
|
198.161980
|
|
LMFA07010905
|
Hexyl 2-methyl-4-pentenoate
|
hexyl 2-methylpent-4-enoate
|
WE 12:1
|
C12H22O2
|
198.161980
|
|
LMFA07010684
|
Arachidyl linolenate
|
eicosanyl 9Z,12Z,15Z-octadecatrienoate
|
WE 38:3
|
C38H70O2
|
558.537581
|
|
LMFA01160013
|
(2R)-2-[(1R)-1-hydroxy-18-{(1S,2R)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
(2R)-2-[(1R)-1-hydroxy-18-{(1S,2R)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
FA 85:1;O2
|
C85H168O4
|
1253.294263
|
|
LMFA01160013
|
(2R)-2-[(1R)-1-hydroxy-18-{(1S,2R)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
(2R)-2-[(1R)-1-hydroxy-18-{(1S,2R)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
FA 85:1;O2
|
C85H168O4
|
1253.294263
|
|
LMFA01160013
|
(2R)-2-[(1R)-1-hydroxy-18-{(1S,2R)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
(2R)-2-[(1R)-1-hydroxy-18-{(1S,2R)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
FA 85:1;O2
|
C85H168O4
|
1253.294263
|
|
LMFA01160013
|
(2R)-2-[(1R)-1-hydroxy-18-{(1S,2R)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
(2R)-2-[(1R)-1-hydroxy-18-{(1S,2R)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
FA 85:1;O2
|
C85H168O4
|
1253.294263
|
|
LMFA01160013
|
(2R)-2-[(1R)-1-hydroxy-18-{(1S,2R)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
(2R)-2-[(1R)-1-hydroxy-18-{(1S,2R)-2-[(17R,18R)-17-methoxy-18-methylhexatriacontyl]cyclopropyl}octadecyl]hexacosanoic acid
|
FA 85:1;O2
|
C85H168O4
|
1253.294263
|
|
LMFA03050030
|
8-HETrE
|
(9E,11Z,14Z)-8-hydroxyicosa-9,11,14-trienoic acid
|
FA 20:3;O
|
C20H34O3
|
322.250796
|
|
LMFA03050030
|
8-HETrE
|
(9E,11Z,14Z)-8-hydroxyicosa-9,11,14-trienoic acid
|
FA 20:3;O
|
C20H34O3
|
322.250796
|
|
LMFA03020052
|
14-carboxy-15,16,17,18,19,20-hexanor-leukotriene E3
|
(3Z,5E,7E,9R,10S)-9-(((R)-2-amino-2-carboxyethyl)thio)-10-hydroxytetradeca-3,5,7-trienedioic acid
|
|
C17H25NO7S
|
387.135175
|
|
LMFA03020052
|
14-carboxy-15,16,17,18,19,20-hexanor-leukotriene E3
|
(3Z,5E,7E,9R,10S)-9-(((R)-2-amino-2-carboxyethyl)thio)-10-hydroxytetradeca-3,5,7-trienedioic acid
|
|
C17H25NO7S
|
387.135175
|
|
LMFA03020052
|
14-carboxy-15,16,17,18,19,20-hexanor-leukotriene E3
|
(3Z,5E,7E,9R,10S)-9-(((R)-2-amino-2-carboxyethyl)thio)-10-hydroxytetradeca-3,5,7-trienedioic acid
|
|
C17H25NO7S
|
387.135175
|
|
LMFA01160004
|
(20E)-2-docosyl-3-hydroxy-39-(nonadecan-2-yloxy)-39-oxononatriacont-20-enoic acid
|
(20E)-2-docosyl-3-hydroxy-39-(nonadecan-2-yloxy)-39-oxononatriacont-20-enoic acid
|
FA 80:2;O3
|
C80H156O5
|
1197.195278
|
|
LMFA01160004
|
(20E)-2-docosyl-3-hydroxy-39-(nonadecan-2-yloxy)-39-oxononatriacont-20-enoic acid
|
(20E)-2-docosyl-3-hydroxy-39-(nonadecan-2-yloxy)-39-oxononatriacont-20-enoic acid
|
FA 80:2;O3
|
C80H156O5
|
1197.195278
|
|
LMFA01160004
|
(20E)-2-docosyl-3-hydroxy-39-(nonadecan-2-yloxy)-39-oxononatriacont-20-enoic acid
|
(20E)-2-docosyl-3-hydroxy-39-(nonadecan-2-yloxy)-39-oxononatriacont-20-enoic acid
|
FA 80:2;O3
|
C80H156O5
|
1197.195278
|
|
LMFA03050023
|
11,12,15-TriHETRE
|
(8E,11Z,13E)-11,12,15-trihydroxyicosa-8,11,13-trienoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240626
|
|
LMFA03050023
|
11,12,15-TriHETRE
|
(8E,11Z,13E)-11,12,15-trihydroxyicosa-8,11,13-trienoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240626
|
|
LMFA07050168
|
2'-(5''-phosphoribosyl)-3'-dephospho-CoA
|
2'-(5-phospho-D-ribofuranosyl)adenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}
|
|
C26H44N7O20P3S
|
899.157469
|
|
LMFA07050168
|
2'-(5''-phosphoribosyl)-3'-dephospho-CoA
|
2'-(5-phospho-D-ribofuranosyl)adenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}
|
|
C26H44N7O20P3S
|
899.157469
|
|
LMFA07050168
|
2'-(5''-phosphoribosyl)-3'-dephospho-CoA
|
2'-(5-phospho-D-ribofuranosyl)adenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}
|
|
C26H44N7O20P3S
|
899.157469
|
|
LMFA07050168
|
2'-(5''-phosphoribosyl)-3'-dephospho-CoA
|
2'-(5-phospho-D-ribofuranosyl)adenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}
|
|
C26H44N7O20P3S
|
899.157469
|
|
LMFA07050168
|
2'-(5''-phosphoribosyl)-3'-dephospho-CoA
|
2'-(5-phospho-D-ribofuranosyl)adenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}
|
|
C26H44N7O20P3S
|
899.157469
|
|
LMFA07050304
|
cis-tetradec-3-enoyl-CoA
|
3Z-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297925
|
|
LMFA07050304
|
cis-tetradec-3-enoyl-CoA
|
3Z-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297925
|
|
LMFA07050304
|
cis-tetradec-3-enoyl-CoA
|
3Z-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297925
|
|
LMFA07050304
|
cis-tetradec-3-enoyl-CoA
|
3Z-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297925
|
|
LMFA07050304
|
cis-tetradec-3-enoyl-CoA
|
3Z-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297925
|
|
LMFA07010705
|
(Z)-8-Decene-4,6-diyn-1-yl 3-methylbutanoate
|
(8Z)-dec-8-en-4,6-diyn-1-yl 3-methylbutanoate
|
WE 15:5
|
C15H20O2
|
232.146330
|
|
LMFA01160024
|
methoxy mycolic acid
|
2-{1-hydroxy-18-[2-(17-methoxy-18-methylhexatriacontyl)cyclopropyl]octadecyl}tetracosanoic acid
|
FA 83:1;O2
|
C83H164O4
|
1225.262963
|
|
LMFA01160024
|
methoxy mycolic acid
|
2-{1-hydroxy-18-[2-(17-methoxy-18-methylhexatriacontyl)cyclopropyl]octadecyl}tetracosanoic acid
|
FA 83:1;O2
|
C83H164O4
|
1225.262963
|
|
LMFA01160024
|
methoxy mycolic acid
|
2-{1-hydroxy-18-[2-(17-methoxy-18-methylhexatriacontyl)cyclopropyl]octadecyl}tetracosanoic acid
|
FA 83:1;O2
|
C83H164O4
|
1225.262963
|
|
LMFA01160024
|
methoxy mycolic acid
|
2-{1-hydroxy-18-[2-(17-methoxy-18-methylhexatriacontyl)cyclopropyl]octadecyl}tetracosanoic acid
|
FA 83:1;O2
|
C83H164O4
|
1225.262963
|
|
LMFA01160024
|
methoxy mycolic acid
|
2-{1-hydroxy-18-[2-(17-methoxy-18-methylhexatriacontyl)cyclopropyl]octadecyl}tetracosanoic acid
|
FA 83:1;O2
|
C83H164O4
|
1225.262963
|
|
LMFA07010716
|
2-Hexenoylcholine
|
{2-[(2E)-hex-2-enoyloxy]ethyl}trimethylazanium
|
|
C11H22NO2
|
200.165054
|
|
LMFA07070027
|
(9Z,12Z,15Z)-3-hydroxyoctadecatrienoylcarnitine
|
3-{[(9Z,12Z,15Z)-3-hydroxyoctadeca-9,12,15-trienoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 18:3;O
|
C25H43NO5
|
437.314124
|
|
LMFA07070027
|
(9Z,12Z,15Z)-3-hydroxyoctadecatrienoylcarnitine
|
3-{[(9Z,12Z,15Z)-3-hydroxyoctadeca-9,12,15-trienoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 18:3;O
|
C25H43NO5
|
437.314124
|
|
LMFA01030982
|
4-ene-Valproic acid
|
2-propylpent-4-enoic acid
|
FA 8:1
|
C8H14O2
|
142.099380
|
|
LMFA01030982
|
4-ene-Valproic acid
|
2-propylpent-4-enoic acid
|
FA 8:1
|
C8H14O2
|
142.099380
|
|
LMFA07050100
|
(1-hydroxycyclohexyl)acetyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(1-hydroxycyclohexyl)acetyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 8:1;O
|
C29H48N7O18P3S
|
907.198939
|